采用患者来源球体和无血清条件研究胶质瘤细胞迁移时microRNA谱的变化
本研究使用患者来源的胶质母细胞瘤球体建立无血清迁移实验,比较最大迁移速度时分离的迁移细胞与对应球体的miRNA表达,发现30个差异表达miRNA(13个上调、17个下调)。实验性过表达miR-1227后迁移率非显著增加,过表达miR-32和miR-222后迁移率显著降低。
要点
- 无血清迁移实验中,迁移细胞较对应球体有13个miRNA上调和17个miRNA下调。
- 过表达miR-1227后迁移率非显著增加,过表达miR-32或miR-222后迁移率显著降低。
- miR-1227可能关联迁移增加,miR-32和miR-222可能关联迁移减少。
核心结论
- 使用避免血清诱导迁移的实验,识别出胶质瘤细胞迁移时microRNA谱的变化。
- miRNA谱分析和功能验证均提示miR-1227可能关联迁移增加,miR-32和miR-222可能关联迁移减少。
- 这些miRNA可能代表迁移胶质瘤细胞的潜在新靶点。
研究设计与样本
- 使用患者来源的胶质母细胞瘤球体培养进行新型无血清迁移实验。
- 用OpenArray实时PCR系统比较最大迁移速度时分离的迁移肿瘤细胞与对应球体的miRNA表达。
主要发现
- miRNA谱分析显示30个miRNA差异表达。
- 迁移细胞与对应球体相比,13个miRNA上调、17个miRNA下调。
- 过表达miR-1227后观察到迁移率非显著增加。
- 过表达miR-32和miR-222后观察到迁移率显著降低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Glioblastoma multiforme (GBM) is the most frequent malignant primary brain tumor. A major reason for the overall median survival being only 14.6 months is migrating tumor cells left behind after surgery. Another major reason is tumor cells having a so-called cancer stem cell phenotype being therefore resistant towards traditional chemo- and radiotherapy. A group of novel molecular targets are microRNAs (miRNAs). MiRNAs are small non-coding RNAs exerting post-transcriptional regulation of gene expression. The aim of this study was to identify differentially expressed miRNAs in migrating GBM cells using serum-free stem cell conditions. We used patient-derived GBM spheroid cultures for a novel serum-free migration assay. MiRNA expression of migrating tumor cells isolated at maximum migration speed was compared with corresponding spheroids using an OpenArray Real-Time PCR System. The miRNA profiling revealed 30 miRNAs to be differentially expressed. In total 13 miRNAs were upregulated and 17 downregulated in migrating cells compared to corresponding spheroids. The three most deregulated miRNAs, miR-1227 (up-regulated), miR-32 (down-regulated) and miR-222 (down-regulated), were experimentally overexpressed. A non-significantly increased migration rate was observed after miR-1227 overexpression. A significantly reduced migration rate was observed after miR-32 and miR-222 overexpression. In conclusion a shift in microRNA profile upon glioma cell migration was identified using an assay avoiding serum-induced migration. Both the miRNA profiling and the functional validation suggested that miR-1227 may be associated with increased migration and miR-32 and miR-222 with decreased migration. These miRNAs may represent potential novel targets in migrating glioma cells.
引用
- Munthe S, Halle B, Boldt HB, et al. Shift of microRNA profile upon glioma cell migration using patient-derived spheroids and serum-free conditions. J Neurooncol. 2017. PMID: 28091986. doi:10.1007/s11060-016-2356-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。